Then we had Herman Pontzer on and we talked about metabolic adaptation from the burn side, right the reason you can't marathon your way to weight loss because your body's just going to adjust
In phase 2 trials, 1-2% of retatrutide participants experienced biliary disorders, including cholecystitis (1 participant) and cholelithiasis (2 participants)
For where these oral and higher-dose options sit among the candidates now in development, see the 2026 GLP-1 clinical pipeline, part of the broader GLP-1 and metabolic disease picture
Monthly monitoring for the first year For the first 12 months after stopping, monthly check-ins with yourself (and ideally a healthcare provider) help catch any slow drift before it becomes a significant regain
Yes, one of GLP 1 & GIP therapys primary functions is to reduce appetite
How to inject retatrutide Read the instructions Before you start using retatrutide it is essential to read the Instructions for Use Guide carefully, to have a better understanding of the dosage and complications attached to every option